Navigation Links
Metabasis Therapeutics Presents Results of Preclinical Studies for,MB07811, Its Novel Product Candidate for the Treatment of,Hyperlipidemia, at the Endocrine Society's Annual Meeting

d costly chronic diseases. By applying our proprietary technologies and scientific expertise, including unique capabilities for targeting the liver and liver pathways, the Company has established a pipeline that includes preclinical and clinical product candidates targeting metabolic diseases such as diabetes, hyperlipidemia and obesity, as well as liver diseases such as hepatitis and primary liver cancer. Metabasis has developed several proprietary technologies for use in discovering and optimizing drugs, including the NuMimetic(TM) and HepDirect(R) technologies. Metabasis is continuing to identify and develop new product candidates using its proprietary technologies and expertise.

Forward-Looking Statements:

Statements in this press release that are not strictly historical in nature constitute "forward-looking statements." Such statements include, but are not limited to, references to the pre-clinical and clinical trial results, potential safety and efficacy and further development of MB07811. Such forward-looking statements involve known and unknown risks, uncertainties and other factors which may cause Metabasis' actual results to be materially different from historical results or from any results expressed or implied by such forward-looking statements. These factors include, but are not limited to, the progress and timing of development for Metabasis' product candidates; the fact that positive results obtained during early development do not necessarily mean later development will succeed; serious adverse side effects of, or serious adverse events related to, Metabasis' product candidates or proprietary technologies; difficulties or delays in development, testing, obtaining regulatory approval, producing and marketing Metabasis' product candidates; the potential and progress of pre-clinical compounds and programs; and other factors discussed in the "Risk Factors" section of Metabasis' Quarterly Report on Form 10-Q for the year ended March 31, 2007
'"/>




Page: 1 2 3 4

Related medicine technology :

1. Metabasis to Present at C.E. Unterberg, Towbin Emerging Growth Conference and Attend Pacific Growth Equities Conference
2. Metabasis Therapeutics to Present Poster at American Association for Cancer Research
3. Cell Therapeutics, Inc. Management to Discuss Todays Announcement of Interim Pixantrone Study Results
4. Halozyme Therapeutics Enhanze Technology Large Protein Molecule Therapeutic Clinical Trial Results Presented at the 34th Annual Meeting of the Controlled Release Society
5. CV Therapeutics Identifies Potential Anti-Diabetic Mechanism of Action for Ranexa
6. Fat Kills Cancer: Turning Stem Cells from Fat Tissue into Personalized, Cancer-Targeted Therapeutics
7. A 4-Week Therapy with Transition Therapeutics E1-I.N.T. Leads to Sustained Reductions in Blood Glucose Levels for 6 Months Post-treatment in Type 2 Diabetes Patients
8. Clinical Trial Suggests Bone Marrow Stem Cells Are Useful for Spinal Cord Injury; PrimeCell Therapeutics Provided Pre-Clinical Study
9. Opexa Therapeutics Reports Positive Top-line Data in Phase I/II Extension Trial with Tovaxin for Multiple Sclerosis
10. Orexigen Therapeutics to Present Data on Contrave Impact on Visceral Fat and Insulin Resistance at American Diabetes Association 67th Scientific Sessions in Chicago June 23
11. Allos Therapeutics Reports Results for Phase 3 Enrich Study of Efaproxyn in Women With Brain Metastases Originating From Breast Cancer
Post Your Comments:
(Date:5/28/2015)... , May 27, 2015 The amount ... billion in 2014 and with growth of 8% will ... categories out of pocket: directly on expenditures, co-pays as ... purchases, and on premiums.  The publisher made its finding ... in the United States . ...
(Date:5/28/2015)...  Merck KGaA, Darmstadt, Germany ... high-tech products in healthcare, life science and performance ... the fertility technologies expert Genea Biomedx, an Australian ... couples create families. With this partnership, Merck KGaA, ... market leader in drugs for Assisted Reproductive Treatment ...
(Date:5/28/2015)... 27, 2015 Research and Markets ( ... PharmaBiotech,s new report "Proteomics - Technologies, Markets ... This report describes and evaluates the proteomic technologies ... discovery, molecular diagnostics and practice of medicine in ... the 21st century. Most commonly used technologies are ...
Breaking Medicine Technology:Report: U.S. Out-of-Pocket Healthcare Spending Reaches $416 Billion 2Report: U.S. Out-of-Pocket Healthcare Spending Reaches $416 Billion 3Merck KGaA, Darmstadt, Germany, as Pioneer in Assisted Reproductive Treatments, Takes Leading Role in Fertility Technologies, Announces a Global Collaboration Agreement with Genea Biomedx 2Merck KGaA, Darmstadt, Germany, as Pioneer in Assisted Reproductive Treatments, Takes Leading Role in Fertility Technologies, Announces a Global Collaboration Agreement with Genea Biomedx 3Merck KGaA, Darmstadt, Germany, as Pioneer in Assisted Reproductive Treatments, Takes Leading Role in Fertility Technologies, Announces a Global Collaboration Agreement with Genea Biomedx 4Global Proteomics Market 2015-2024 - Technologies, Markets and Companies (Updated Edition) 2Global Proteomics Market 2015-2024 - Technologies, Markets and Companies (Updated Edition) 3
... Aug. 31 /PRNewswire/ Reportlinker.com announces that a new ... Insulin Pumps - Global Pipeline ... http://www.reportlinker.com/p0254536/Insulin-Pumps---Global-Pipeline-Analysis-Opportunity-Assessment-and-Market-Forecasts-to-2016.html ... and Market Forecasts to 2016 ...
... (NYSE: HRC ) today announced the appointment ... Chain.  Currently serving as General Manager for Global Lean ... on September 13, 2010.  In addition to his responsibilities ... will be responsible for all aspects of Hill-Rom,s global ...
Cached Medicine Technology:Reportlinker Adds Insulin Pumps - Global Pipeline Analysis, Opportunity Assessment and Market Forecasts to 2016 2Reportlinker Adds Insulin Pumps - Global Pipeline Analysis, Opportunity Assessment and Market Forecasts to 2016 3Reportlinker Adds Insulin Pumps - Global Pipeline Analysis, Opportunity Assessment and Market Forecasts to 2016 4Reportlinker Adds Insulin Pumps - Global Pipeline Analysis, Opportunity Assessment and Market Forecasts to 2016 5Reportlinker Adds Insulin Pumps - Global Pipeline Analysis, Opportunity Assessment and Market Forecasts to 2016 6Reportlinker Adds Insulin Pumps - Global Pipeline Analysis, Opportunity Assessment and Market Forecasts to 2016 7Reportlinker Adds Insulin Pumps - Global Pipeline Analysis, Opportunity Assessment and Market Forecasts to 2016 8Reportlinker Adds Insulin Pumps - Global Pipeline Analysis, Opportunity Assessment and Market Forecasts to 2016 9Hill-Rom Appoints Scott Jeffers as Senior Vice President, Global Supply Chain 2
(Date:5/28/2015)... (PRWEB) May 28, 2015 The CEO ... announced a just launched blog series which provides analysis ... Hosted on the “R. Bruce Dalglish” profile on Blogger.com, ... R. Bruce Dalglish’s corporate experience. , “Throughout my ... workplace cultures have upon the overall success of businesses,” ...
(Date:5/28/2015)... Richmond, VA (PRWEB) May 28, 2015 ... Premium Frozen Yogurt will raise money to help the ... kids fighting muscular dystrophy and related life-threatening diseases that ... MDA Summer Camp mobile program. , From June 1 ... mobiles that offer customers the opportunity to help send ...
(Date:5/28/2015)... McLean, VA (PRWEB) May 28, 2015 ... solutions, announced today that it is releasing BlueEHS, the ... an Amazon Machine Image for the benefit of all ... developer of BlueEHS, a first of its kind, Freemium, ... customizable Electronic Health Records (EHR) with an integrated practice ...
(Date:5/28/2015)... CompanionDx , a Houston-based genomic ... will present their integrated solution of next-generation sequencing ... American Society of Clinical Oncology (ASCO) in Chicago ... in a patient’s tumor via a small biopsy ... or somatic mutations. Pharmacogenomics testing establishes a clear ...
(Date:5/28/2015)... Sexual Health Innovations, a nonprofit organization ... and wellbeing in the United States, announced this ... will be the first institution to adopt Callisto, ... system. , Callisto is designed to provide ... for college sexual assault survivors, to give schools ...
Breaking Medicine News(10 mins):Health News:R. Bruce Dalglish, CEO of Alliance Hospice, Introduces New Blog Series On Positive Corporate Culture 2Health News:sweetFrog and MDA Join Forces to Send Kids with Muscle Disease to Summer Camp 2Health News:sweetFrog and MDA Join Forces to Send Kids with Muscle Disease to Summer Camp 3Health News:BlueEHS, the Electronic Health Solution, now available on Amazon AWS Market place 2Health News:BlueEHS, the Electronic Health Solution, now available on Amazon AWS Market place 3Health News:CompanionDx® Launches Integrated Genomic Solution at ASCO Meeting 2Health News:University of San Francisco Becomes First in the Nation to Adopt College Sexual Assault Reporting System 2Health News:University of San Francisco Becomes First in the Nation to Adopt College Sexual Assault Reporting System 3
... -- positron emission tomography (PET) and magnetic resonance imaging ... in a single scanner. , MRI scans provide exquisite ... -- which follow a radioactive tracer in the body ... Simon Cherry, professor and chair of biomedical engineering at ...
... microenvironment for disease treatments , , FRIDAY, March 7 ... into all types of blood cells, originate and are ... This finding may help researchers replicate the specific embryonic ... lab so doctors can treat patients with diseases such ...
... ANTONIO, March 7 Stabilix Corporation, a software,development ... announced that they have released a new more ... is a healthcare consumer,tool that allows the individual ... and keep personal health records. The much,anticipated version ...
... protect its Intellectual Property that, has been employed in Minimally Invasive Surgical ... ... MARIETTA, Ga., March 7 In a much anticipated decision,Judge Joy ... liable for expenses and attorneys,fees incurred by ERBE while defending against Dr. ...
... Neuromedical, Inc.,announced today that it has completed the ... manufacturer of therapeutic implantable devices,for interventional (minimally invasive) ... include products such as the DSB (Detachable,Silicone Balloon) ... the Endeavor Balloon Catheter, both of which have ...
... RARITAN, N.J., March 6 Johnson & ... that the U.S. Food and Drug,Administration (FDA) ... second New,Drug Application for the antibiotic DORIBAX(TM) ... 2007, seeks approval to market DORIBAX,to treat ...
Cached Medicine News:Health News:Blood Stem Cells Originate in the Placenta 2Health News:Stabilix Publishes Version 2 of Health Companion, a Personal Healthcare Management Tool 2Health News:ERBE Perseveres Yet Again in Opposition to Dr. Jerome Canady, and is Awarded More Than One Million Dollars 2Health News:Nfocus Neuromedical Announces Acquisition of StarFire Medical 2Health News:FDA Extends Review Timeline for Additional Indication for Antibiotic DORIBAX(TM) 2Health News:FDA Extends Review Timeline for Additional Indication for Antibiotic DORIBAX(TM) 3
... system mirrors a 96-well plate in format, ... products to take place easily and with ... Loading can be carried out directly with a ... the industry two sets of off-set marker ...
... "Four gels in one tank" electrophoresis. By using ... samples or more in one compact gel tank, ... ensure even migration, the electrode height is adjustable ... Ideal for high throughput procedures, an added benefit ...
... on the UV-transparent gel bed using small sliding ... or outside the unit using a UV-transparent gel ... 10cm long. Different colors are offered for any ... and tape are not included. Gel tray is ...
... horizontal electrophoresis unit for agarose gel is made of ... for convenience and an electrode protection device.Combs, gel tray ... ... ...
Medicine Products: